WHO’s your exact match? Flucelvax® Quad Educational Module
This course has been updated for the 2025 flu season
You call the shots! An education module on flu and FLUAD® Quad
This course has been updated for the 2025 flu season
A practical guide to discussing advanced flu vaccines with patients.
Australian GP, Dr Sarah Chu discusses the burden of influenza and the vaccination environment in Australia with parallels to New Zealand. Pharmacist at Life Pharmacy, Eastridge, Krenare Pireva talks about the growing vaccination role of pharmacy and Community Nurse Prescriber, Vicky Andrews gives us her perspective on vaccinating older patients with FLUAD® Quad and how they are gearing up for the arrival of Flucelvax® Quad this year.
The role of observational real world data with relevance to influenza with a focus on Flucelvax Quad.
Presentations from Dr Janine Paynter on real world or observational studies of vaccines and Professor Tino Schwarz on the clinical benefits of a cell-based influenza vaccine and his experience using Flucelvax® Quad.
All Things Influenza
Presentations from Associate Professor John Litt – “What’s New with Flu?”; Registered nurses, Maree McKenna and Paige Drummond – “Managing Flu in a primary care context at Masterton Medical”; and Medical Microbiology scientist, Ben Harris – “Influenza in the context of other emerging infectious diseases”.
Tailoring Vaccines for Different Ages
Dr George Kassianos, the National Immunisation Lead of the Royal College of General Practitioners in the UK, and Dr Edwin Reynolds from IMAC, present their thoughts on tailoring vaccination by age group
Vaccines to Prevent Heart Attacks
Professor Stefan Gravenstein, presents on the effects of aging on immunology and infection, and then links that back to heart attacks, and vaccines to help prevent heart attacks.
Research Review educational series
This review summarises influenza prevention and control in the context of the attenuating effects of ageing on immunity and immune response to vaccination and discusses the history and role of adjuvants in vaccine technology, with emphasis on the use of the MF59-adjuvanted vaccine to increase influenza protection in older adults
